| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 6 |
| 1 | CYCLOPHOSPHAMIDE | 4 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 4 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 4 |
| 4 | DOXORUBICIN | 4 |
| 5 | PREDNISONE | 4 |
| 6 | DOXORUBICIN HYDROCHLORIDE | 3 |
| 7 | ETOPOSIDE PHOSPHATE | 3 |
| 8 | VINCRISTINE SULFATE | 3 |
| 9 | ETOPOSIDE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ETOPOSIDE PHOSPHATE | 3 | 0.0018 |
| 1 | POLATUZUMAB VEDOTIN | 2 | 0.0002 |
| 2 | BENDAMUSTINE HYDROCHLORIDE | 1 | 0.0001 |
| 3 | VINCRISTINE SULFATE | 3 | 0.0001 |
| 4 | BRENTUXIMAB VEDOTIN | 1 | 0.0001 |
| 5 | DOXORUBICIN HYDROCHLORIDE | 3 | 0.0001 |
| 6 | BENDAMUSTINE HCL | 1 | 0.0001 |
| 7 | IFOSFAMIDE FOR INJECTION | 1 | 0.0000 |
| 8 | DOXORUBICIN | 4 | 0.0000 |
| 9 | RITUXIMAB | 6 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD30-directed Immunoconjugate [EPC] | 1 | 0.0001 |
| 1 | Topoisomerase Inhibitor [EPC] | 2 | 0.0000 |
| 2 | Alkylating Drug [EPC] | 5 | 0.0000 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 6 | 0.0000 |
| 4 | Calcineurin Inhibitor Immunosuppressant [EPC] | 1 | 0.0000 |
| 5 | Janus Kinase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 2 | 0.0000 |
| 7 | Corticosteroid [EPC] | 5 | 0.0000 |
| 8 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 1 | 0.0000 |